glp 1 gip dual agonist mechanism of action Major physiological roles GLP-1 and GIP. Tirzepatide is acting as an GLP-1 Agonists For Obesity In

The Triple Threat: Retatrutides Glucagon Component Retatrutide is often referred to as a GIP GLP-1 Glucagon agonist , setting it apart as the first drug of its kind to target three distinct metabolic pathways

Randomized, double-blind, phase 3 trial of triple therapy with dapagliflozin add-on to saxagliptin plus metformin in type 2 diabetes

Mentlein R, Gallwitz B, Schmidt WE

Despite the possibility of adverse events, GLP-1 RAs continue to represent a crucial therapeutic modality for metabolic disturbances

doi: 10.1161/CIRCULATIONAHA.112.091215

From 2004 to 2009, an analysis of the database revealed a six-fold increase in pancreatitis incidents linked to the DPP-4 inhibitor sitagliptin and the GLP-1 mimetic exenatide, the first two GLP-1-based medications marketed in the US [51]